Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-02 @ 9:07 AM
Study NCT ID:
NCT04709458
Status:
UNKNOWN
Last Update Posted:
2022-05-03
First Post:
2021-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
Sponsor:
Taiga Biotechnologies, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TBX-2400-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None